We are live on
!
Find out more
Primecap Management Portfolio holdings
AUM
$127B
1-Year Est. Return
44.11%
This Fund
S&P 500
This Quarter
Est. Return
+12.35%
1 Year Est. Return
+44.11%
3 Year Est. Return
+121.64%
5 Year Est. Return
+154.22%
10 Year Est. Return
+724.54%
AUM
$136B
AUM Growth
+$12.5B
(+10%)
Cap. Flow
-$1.5B
Cap. Flow
% of AUM
-1.11%
Top 10 Holdings %
Top 10 Hldgs %
28.12%
Holding
295
New
4
Increased
72
Reduced
149
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Elanco Animal Health
ELAN
|
+$789M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$158M |
| 3 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$91.7M |
| 4 |
CVS Health
CVS
|
+$88.1M |
| 5 |
Novartis
NVS
|
+$86.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$896M |
| 2 |
NVIDIA
NVDA
|
+$256M |
| 3 |
Amgen
AMGN
|
+$155M |
| 4 |
Cisco
CSCO
|
+$138M |
| 5 |
Adobe
ADBE
|
+$131M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.33% |
| 2 | Healthcare | 24.5% |
| 3 | Industrials | 15.11% |
| 4 | Consumer Discretionary | 9.46% |
| 5 | Financials | 9.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NUAN
126
DELISTED
Nuance Communications, Inc.
NUAN
| $154M | 0.11% |
10,519,853
-86,510
| -0.8% | -$1.2M |
|
127
Curtiss-Wright
CW
$25.5B
| $152M | 0.11% |
1,343,700
| – | – |
|
|
PRO
128
DELISTED
PROS Holdings
PRO
| $140M | 0.1% |
3,320,400
+504,500
| +18% | +$19.1M |
|
129
IMAX
IMAX
$2.66B
| $136M | 0.1% |
5,996,600
-29,700
| -0.5% | -$634K |
|
130
Marriott International
MAR
$92.3B
| $133M | 0.1% |
1,065,196
+400
| +0% | +$47.1K |
|
|
EPZM
131
DELISTED
Epizyme, Inc
EPZM
| $127M | 0.09% |
10,253,801
+697,274
| +7% | +$7.8M |
|
132
MaxLinear
MXL
$6.8B
| $125M | 0.09% |
4,901,334
+99,190
| +2% | +$2.17M |
|
|
ONC
133
BeOne Medicines Ltd
ONC
$39.4B
| $121M | 0.09% |
920,439
-1,100
| -0.1% | -$148K |
|
134
General Dynamics
GD
$106B
| $119M | 0.09% |
700,990
+3,000
| +0.4% | +$505K |
|
|
SPPI
135
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $118M | 0.09% |
11,059,000
+25,270
| +0.2% | +$271K |
|
136
Salesforce
CRM
$158B
| $116M | 0.09% |
735,060
+5,700
| +0.8% | +$883K |
|
137
Rockwell Automation
ROK
$49B
| $116M | 0.09% |
658,795
-30
| -0% | -$5.1K |
|
138
MGM Resorts International
MGM
$11.2B
| $115M | 0.08% |
4,464,200
| – | – |
|
139
Comcast
CMCSA
$90B
| $109M | 0.08% |
2,724,100
| – | – |
|
140
Jabil
JBL
$35.8B
| $103M | 0.08% |
3,885,387
-53,300
| -1% | -$1.42M |
|
141
Edwards Lifesciences
EW
$51.7B
| $102M | 0.08% |
1,605,000
| – | – |
|
|
EA
142
DELISTED
Electronic Arts
EA
| $101M | 0.07% |
989,925
-127,500
| -11% | -$12.1M |
|
143
Ulta Beauty
ULTA
$24.3B
| $98.1M | 0.07% |
281,400
| – | – |
|
|
CTRA
144
DELISTED
Coterra Energy
CTRA
| $91.8M | 0.07% |
3,518,154
+41,300
| +1% | +$1.04M |
|
145
IDEX
IEX
$17.3B
| $90.2M | 0.07% |
594,550
-760
| -0.1% | -$107K |
|
146
CSX Corp
CSX
$93.1B
| $89.3M | 0.07% |
3,582,600
-1,734,000
| -33% | -$40.1M |
|
147
Standard BioTools
LAB
$314M
| $87.5M | 0.06% |
6,581,443
-89,600
| -1% | -$944K |
|
148
Sanofi
SNY
$104B
| $86.6M | 0.06% |
1,955,700
| – | – |
|
149
SLB Ltd
SLB
$75B
| $86.6M | 0.06% |
1,987,028
-133,864
| -6% | -$5.79M |
|
150
Teradyne
TER
$59.3B
| $80.9M | 0.06% |
2,031,422
-1,200
| -0.1% | -$44.8K |
|
Similar funds
VAM
Primecap Management's Q1 2019 Portfolio in Review
As of Q1 2019, Primecap Management held 295 positions worth $136B, up 10% from $123B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Trading was light in Q1 2019: portfolio turnover was 2%. Primecap Management opened 4 new positions and exited 2, leaving the 295-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 29% a quarter earlier, followed by Healthcare and Industrials.
- Primecap Management's largest Q1 2019 buy was Lyft: 500,000 shares worth $39.1M.
- Primecap Management added most to Elanco Animal Health in Q1 2019, an estimated $789M increase.
- Primecap Management's biggest Q1 2019 reduction was Eli Lilly, cutting an estimated $896M.
- Primecap Management fully exited MINDBODY, Inc. Class A Common Stock in Q1 2019, selling an estimated $5.84M.
- Primecap Management's ten largest holdings make up 28% of its $136B portfolio in Q1 2019.
- Primecap Management opened 4 new positions and closed 2 in Q1 2019.
- Primecap Management's portfolio value rose 10% quarter-over-quarter to $136B.
Based on Primecap Management's 13F filing for Q1 2019, filed 14 May 2019.